=================================== ----------------------------
FORM 3 OMB APPROVAL
=================================== ----------------------------
|_| Check this box if no longer OMB Number 3235-0104
subject to Section 16. Form 4 Expires:
or Form 5 obligations may Estimated average burden
continue. See Instruction 1(b). hours per response...0.5
=================================== ----------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
<TABLE>
<S> <C> <C>
------------------------------------------ ------------------------------------------- ------------------------------------------
1. Name and Address of Reporting Person 2. Date of Event 4. Issuer Name and Ticker or Trading Symbol
Requiring
(Month/Day/Year)
American Bio Corp. 9/06/00 Agritope, Inc. (AGTO)
------------------------------------------ ------------------ --------------------------------------------------------------
(First) (First) (Middle) 3. IRS or Social 5. Relationship of Reporting Person 6. If Amendment, Date of
c/o Harris Moran Seed Company Security Number to Issuer (Check all applicable) Original
555 Condoni Avenue of Reporting ______ Director ___X___ 10% Owner (Month/Day/Year)
------------------------------------------ Person ______ Officer _______ Other
(Street) (Voluntary) (give title (specify 7. Individual or Joint/
36-3087046 below) below) Group
Modesto California 95352-4938 Filing (Check App-
------------------------------------------ N/A licable Line)
(City) (State) (Zip) _X__ Form filed by
One Reporting Person
___ Form filed by
More than One
Reporting Person
------------------ ------------------------ ------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
Table I - Non-Derivative Securities Beneficially Owned
---------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
-------------------------- ---------------- ------------ ----------------------------------- --------------- ------------- ---------
1. Title of Security 2. Amount of 3. Owner- 4. Nature of
(Instr. 4) Securities ship Indirect
Beneficially Form: Beneficial
owned at Direct Ownership
End of Month (D) or (Instr. 5)
(Instr. 4) Indirect
(I)
(Instr. 5)
-------------------------- ---------- ------ ----- ------------- ------ -------------- ---------------- ------------- --------------
-------------------------- ---------- ------ ----- ------------- ------ -------------- ---------------- ------------- --------------
-------------------------- ---------- ------ ----- ------------- ------ -------------- ---------------- ------------- --------------
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
SEC 1474 (7-96)
* If the form is filed by more than one reporting person, see Instruction
5(b)(v).
</TABLE>
Page 1 of 2
<PAGE>
<TABLE>
<CAPTION>
FORM 3 (continued)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially
Owned (e.g., puts, calls, warrants, options, convertible securities)
<S> <C> <C> <C> <C> <C>
----------------- ---------- ----------------- ------------ ----------------- ------------
1.Title of Deri- 2.Date 3.Title and Amount 4.Conversion 5.Ownership 6.Nature of
vative Security Exercis- of Securities or Exercise Form of Beneficial
(Instr.4) able and Underlying Price of Derivative Indirect
Expiration Derivative Derivative Security: Ownership
Date Security (Instr. 4) Security Direct (D) (Instr. 5)
(Month/Day/ or Indirect (I)
Year) (Instr. 5)
------ ----- ----------------
Date Expi- Title Amount
Exer- ration or Number
cisable Date of Shares
-------------- ------- ----- -------- -------- -------------------------------------------
Series A (1) N/A Common 564,285 N/A D --
Convertible Stock
Preferred Stock
-------------- ------- ----- -------- ------- -------------------------------------------
Warrants to (2) 9/28/04 Common 87,500 $7.00 D --
Purchase Stock
Series A
Convertible
Preferred Stock
-------------- ------- ----- -------- ------- ---------------------------------------
</TABLE>
Explanation of Responses:
(1) The shares of Series A Preferred Stock are convertible, at the option of
the holder thereof, at any time and from time to time, without the payment
of additional consideration by the holder thereof.
(2) The warrants are exercisable at any time prior to 5 p.m., U.S. Pacific
Time, on the expiration date.
Note: American Bio Corp.'s future filings with respect to these Agritope, Inc.
securities will be made jointly with the filings of Vilmorin Clause &
Cie, an indirect beneficial owner of the securities.
AMERICAN BIO CORP.
By: /s/ Pierre Lefebvre 9/30/00
Name: Pierre Lefebvre
Title: CEO
**(Signature of Reporting Person) Date
**Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually
signed. If space provided is insufficient, see Instruction 6 for
procedure.
Page 2 of 2
